Transforming the landscape of early cancer detection using blood tests-Commentary on current methodologies and future prospects

Minetta C Liu, Minetta C Liu

Abstract

Early cancer detection should lead to an overall stage shift, less-intensive treatments and better patient outcomes. Current recommended screening programmes are limited to a handful of individual cancers. A multi-cancer early detection test that simultaneously detects and localises multiple cancers could reduce the morbidity and mortality associated with cancer.

Conflict of interest statement

The Mayo Clinic was compensated for M.C.L.’s advisory board activities for GRAIL, Inc.

Figures

Fig. 1. Attributes of multi-cancer detection methods.
Fig. 1. Attributes of multi-cancer detection methods.
MCED multi-cancer early detection, TOO tumour of origin.

References

    1. Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 2020;31:745–759. doi: 10.1016/j.annonc.2020.02.011.
    1. Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020;369:eabb9601. doi: 10.1126/science.abb9601.
    1. Ahlquist DA. Universal cancer screening: revolutionary, rational, and realizable. npj Precis. Oncol. 2018;2:23. doi: 10.1038/s41698-018-0066-x.
    1. Cescon DW, Bratman SV, Chan SM, Siu LL. Circulating tumor DNA and liquid biopsy in oncology. Nat. Cancer. 2020;1:276–290. doi: 10.1038/s43018-020-0043-5.
    1. Chen X, Gole J, Gore A, He Q, Lu M, Min J, et al. Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. Nat. Commun. 2020;11:3475. doi: 10.1038/s41467-020-17316-z.
    1. Li, B., Wang, C., Xu, J., Fang, S., Qiu, F., Su, J. et al. Multiplatform analysis of early-stage cancer signatures in blood [abstract]. Clin. Cancer Res.26(suppl), A06 (2020).
    1. Li, N., Zhang, Y., Zhu, X., Zhang, Z., Xu, J., Li, B. et al. Methylation profiling of circulating tumor DNA for the detection of ovarian cancer [abstract]. Cancer Res.80(16 suppl), Abstract nr 2302 (2020).
    1. Liang, N., Li, B., Wang, C., Zheng, T., Xu, J., Fang, S. et al. DNA methylation profiling from circulating tumor DNA for early diagnosis of non-small cell lung cancer [abstract]. Cancer Res.79(13 suppl), Abstract nr 816 (2019).

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj